# Ketone Pharmacokinetic Study in HFrEF

> **NCT05757193** · PHASE1 · COMPLETED · sponsor: **Duke University** · enrollment: 20 (actual)

## Conditions studied

- Heart Failure With Reduced Ejection Fraction

## Interventions

- **DIETARY_SUPPLEMENT:** DeltaG (250 mg/kg)
- **DIETARY_SUPPLEMENT:** DeltaG (500 mg/kg)

## Key facts

- **NCT ID:** NCT05757193
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-02
- **Primary completion:** 2024-01-11
- **Final completion:** 2024-01-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-12-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05757193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05757193, "Ketone Pharmacokinetic Study in HFrEF". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05757193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*